The neutrophil-to-lymphocyte ratio (NLR) is a marker that reflects systemic inflammation and organ dysfunction. Its use as a prognostic marker to predict complications following surgery has been recently described in the literature.
The objective of our study was to evaluate the use of postoperative day one (POD1) NLR as a predictor of 30-day outcomes in patients undergoing bariatric surgery.
We performed a retrospective chart review of 789 patients who underwent bariatric surgery at our institution between March 2012 and May 2014. Data were collected from electronic patient records and administrative databases used for quality improvement. POD1 NLR values were obtained from complete blood counts along with a variety of 30-day clinical outcomes. Univariate and multivariable analyses were conducted to determine whether POD1 NLR ≥10 was associated with 30-day outcomes.
Seven-hundred and thirty-seven patients were included in the study. Six-hundred and fifty-three Roux-en-Y gastric bypass surgeries (88.6 %) and 84 sleeve gastrectomy surgeries (11.4 %) were performed. All surgeries were performed laparoscopically. We observed a 4.7 % readmission rate, 2.2 % reoperation rate, 10.7 % postoperative occurrence rate, and 0.1 % mortality rate. After covariate adjustment, POD1 NLR ≥10 was found to be significantly associated with overall complications (OR 1.98, 95 % CI 1.01–3.87), major complications (OR 3.71, 95 % CI 1.76–7.82), reoperation (OR 3.63, 95 % CI 1.14–11.6), and prolonged postoperative length of stay (OR 3.70, 95 % CI 2.2–6.22).
POD1 NLR was independently associated with 30-day outcomes following bariatric surgery. This easily obtained inflammatory marker may be used to help identify patients at a higher risk of developing early complications.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79
World Health Organization (2015) Obesity and overweight. Last accessed 10 May 2016. http://www.who.int/mediacentre/factsheets/fs311/en/
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
Mitka M (2006) Surgery useful for morbid obesity, but safety and efficacy questions linger. JAMA 296:1575–1577
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA (2014) The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg 149:275–287
Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436
Padwal RS, Klarenbach SW, Wang X, Sharma AM, Karmali S, Birch DW, Majumdar SR (2013) A simple prediction rule for all-cause mortality in a cohort eligible for bariatric surgery. JAMA Surg 148:1109–1115
Cawley J, Sweeney MJ, Kurian M, Beane S, New York State Bariatric Surgery Workgroup (2007) Predicting complications after bariatric surgery using obesity-related co-morbidities. Obes Surg 17:1451–1456
Schwartz ML, Drew RL, Chazin-Caldie M (2003) Laparoscopic Roux-en-Y gastric bypass: preoperative determinants of prolonged operative times, conversion to open gastric bypasses, and postoperative complications. Obes Surg 13:734–738
Albanopoulos K, Alevizos L, Natoudi M, Dardamanis D, Menenakos E, Stamou K, Zografos G, Leandros E (2013) C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc 27:864–871
Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30
Vaughan-Shaw PG, Rees JR, King AT (2012) Neutrophil lymphocyte ratio in outcome prediction after emergency abdominal surgery in the elderly. Int J Surg 10:157–162
Forget P, Moreau N, Engel H, Cornu O, Boland B, De Kock M, Yombi JC (2015) The neutrophil-to-lymphocyte ratio (NLR) after surgery for hip fracture (HF). Arch Gerontol Geriatr 60:366–371
Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract 19:337–372
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Johnson AR, Milner JJ, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249:218–238
Aggarwal BB (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30:173–199
Neff KJ, Olbers T, le Roux CW (2013) Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med 11:8
Turner PL, Saager L, Dalton J, Abd-Elsayed A, Roberman D, Melara P, Kurz A, Turan A (2011) A nomogram for predicting surgical complications in bariatric surgery patients. Obes Surg 21:655–662
Warschkow R, Tarantino I, Folie P, Beutner U, Schmied BM, Bisang P (2012) C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg 16:1128–1135
Mr. Da Silva, Mrs. Cleghorn, Dr. Elnahas, Dr. Jackson, Dr. Okrainec, and Dr. Quereshy have no conflicts of interest or financial ties to disclose.
About this article
Cite this article
Da Silva, M., Cleghorn, M.C., Elnahas, A. et al. Postoperative day one neutrophil-to-lymphocyte ratio as a predictor of 30-day outcomes in bariatric surgery patients. Surg Endosc 31, 2645–2650 (2017). https://doi.org/10.1007/s00464-016-5278-y
- Neutrophil-to-lymphocyte ratio (NLR)
- Inflammatory marker